Finance

Lists
IGC:NYSEAMERICAN
IGC Pharma Inc
$0.28
-1.86%
(-0.0053) 1D
Oct 9, 2:51:20 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for IGC...
Open
$0.28
High
$0.28
Low
$0.28
Mkt. cap
29.41M
Avg. vol.
747.58K
Volume
200.79K
52-wk high
$0.45
52-wk low
$0.24
EPS
-$0.08
Beta
0.47
Shares outstanding
103.38M
No. of employees
70
Open
$0.28
High
$0.28
Low
$0.28
Mkt. cap
29.41M
Avg. vol.
747.58K
Volume
200.79K
52-wk high
$0.45
52-wk low
$0.24
EPS
-$0.08
Beta
0.47
Shares outstanding
103.38M
No. of employees
70
News stories
From web sources and news partners
About IGC Pharma Inc
CEO-
Employees70
Founded2005
HeadquartersPotomac, Maryland, United States
SectorPharmaceutical industry
Websiteigcpharma.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2024
Mar 2025
Mar 2026
Jun 2026
Revenue
257.00K
330.00K
317.00K
265.00K
Cost of goods sold
153.00K
176.00K
174.00K
217.00K
Cost of revenue
153.00K
176.00K
262.00K
217.00K
Research and development expenses
852.00K
997.00K
1.27M
1.59M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.13M
619.00K
1.20M
1.41M
Operating expense
1.98M
1.62M
2.51M
2.83M
Total operating expenses
2.14M
1.79M
2.78M
3.05M
Operating income
-1.88M
-1.46M
-2.46M
-2.78M
Other non operating income
49.00K
190.00K
56.00K
1.08M
EBT including unusual items
-1.83M
-1.20M
-1.60M
-2.94M
EBT excluding unusual items
-1.83M
-1.27M
-1.60M
-2.94M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1.83M
-1.20M
-2.40M
-1.82M
Net profit margin
-711.67%
-362.73%
-757.73%
-1,107.92%
Earnings per share
-0.02
-0.01
-0.02
-0.03
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.72M
-1.31M
-2.40M
-2.73M
Gain or loss from assets sale
-
-25.00K
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps